Refund You can refuse the purchased goods without giving a reason
& Leeming, J
Alongside cagrilintide, our metabolic research catalog includes Semaglutide (GLP-1 monoagonist), Tirzepatide (GLP-1/GIP dual agonist), Retatrutide (GLP-1/GIP/glucagon triagonist), AOD-9604 (hGH lipolytic fragment), MOTS-C (mitochondrial metabolic regulator), and 5-Amino-1MQ (NNMT inhibitor)
59 It is encoded by the ALPL gene and exists as four isozymes, intestinal, placental, germ-cell, tissue-nonspecific, and liver/bone/kidney depending upon the site of expression
This makes it a very popular option for targeted hormone therapy
Quick Answer: GLP-1 receptor agonists have not been definitively shown to directly cause clinically significant bone density loss, though the substantial weight reduction they produce may indirectly affect bone metabolism